Abbisko Cayman (FRA:8ZD) Ending Cash Position: €90.82 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8ZD Abbisko Cayman Ltd FRA:8ZD
55 GF Score
Price €0.95
GF Value €1.30
! 5 Warning Signs
View Full Analysis

What is Abbisko Cayman Ending Cash Position?

Abbisko Cayman FRA:8ZD -5.94% 55 Ending Cash Position is €90.82 Mil as of Dec. 2025. GuruFocus rates FRA:8ZD with a GF Score™ of 55/100 and a GF Value™ of €1.30. The stock has 5 warning signs investors should review.

Abbisko Cayman's Ending Cash Position for the quarter that ended in Dec. 2025 was €90.82 Mil.

Abbisko Cayman's quarterly Ending Cash Position increased from Dec. 2024 (€37.98 Mil) to Jun. 2025 (€90.40 Mil) and increased from Jun. 2025 (€90.40 Mil) to Dec. 2025 (€90.82 Mil).

Abbisko Cayman's annual Ending Cash Position declined from Dec. 2023 (€74.24 Mil) to Dec. 2024 (€37.98 Mil) but then increased from Dec. 2024 (€37.98 Mil) to Dec. 2025 (€90.82 Mil).

Abbisko Cayman Ending Cash Position Related Terms

Abbisko Cayman Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Abbisko Cayman's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbisko Cayman Ending Cash Position Chart

Abbisko Cayman Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 147.82 86.91 74.24 37.98 90.82

Abbisko Cayman Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.23 37.98 90.40 90.82 0.00
FRA:8ZD
55GF Score
Abbisko Cayman Ltd FRA:8ZD
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbisko Cayman Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Abbisko Cayman's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=35.106+55.712
=90.82

Abbisko Cayman's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=90.774+0.044000000000004
=90.82

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €90.82 Mil mean?
Abbisko Cayman (FRA:8ZD) has a Ending Cash Position of €90.82 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Abbisko Cayman and its competitors.
Is Abbisko Cayman's Ending Cash Position too high?
Abbisko Cayman's current Ending Cash Position is €90.82 Mil. Overall, Abbisko Cayman has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Abbisko Cayman's Ending Cash Position compare to VRTX and REGN?
Abbisko Cayman's Ending Cash Position of €90.82 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Abbisko Cayman and its competitors. Abbisko Cayman's current Ending Cash Position is €90.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbisko Cayman stock overvalued right now?
Abbisko Cayman (FRA:8ZD) has a current Ending Cash Position of €90.82 Mil. The stock's GF Value™ is €1.30, compared to a current price of €0.95 — trading 26.9% below its estimated fair value. The current Ending Cash Position is €90.82 Mil. Abbisko Cayman's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Abbisko Cayman (FRA:8ZD), the current Ending Cash Position is €90.82 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbisko Cayman (FRA:8ZD) Overvalued in 2026?

Based on GuruFocus' analysis, Abbisko Cayman stock appears to be undervalued. The current stock price of €0.95 is trading 26.9% below its estimated GF Value™ of €1.30.

Key valuation signals for FRA:8ZD:

  • Ending Cash Position: €90.82 Mil
  • GF Value™: €1.30 vs. price of €0.95 (26.9% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the FRA:8ZD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbisko Cayman Business Description

Other Exchanges 02256:Hong Kong
Address Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Abbisko Cayman Ltd is an investment holding company that operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of medicines and differentiated small molecule oncology therapies. The company has pipeline of 21 program candidates, with a primary focus on oncology and pimicotinib has received approval from the China NMPA, and several other candidates are currently in clinical development stage. The company has only one business segment which is the development of medicines. Geographically, the company has it's concentration in European Union and Chinese mainland region.
55GF Score

Get the complete analysis for FRA:8ZD

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.95
Price
€1.30
GF Value